164 related articles for article (PubMed ID: 24083380)
1. Differential PKA activation and AKAP association determines cell fate in cancer cells.
Hedrick ED; Agarwal E; Leiphrakpam PD; Haferbier KL; Brattain MG; Chowdhury S
J Mol Signal; 2013 Oct; 8(1):10. PubMed ID: 24083380
[TBL] [Abstract][Full Text] [Related]
2. TGFβ and IGF1R signaling activates protein kinase A through differential regulation of ezrin phosphorylation in colon cancer cells.
Leiphrakpam PD; Brattain MG; Black JD; Wang J
J Biol Chem; 2018 May; 293(21):8242-8254. PubMed ID: 29599290
[TBL] [Abstract][Full Text] [Related]
3. Akt inhibitor MK-2206 promotes anti-tumor activity and cell death by modulation of AIF and Ezrin in colorectal cancer.
Agarwal E; Chaudhuri A; Leiphrakpam PD; Haferbier KL; Brattain MG; Chowdhury S
BMC Cancer; 2014 Mar; 14():145. PubMed ID: 24581231
[TBL] [Abstract][Full Text] [Related]
4. Cell-permeable peptide-based disruption of endogenous PKA-AKAP complexes: a tool for studying the molecular roles of AKAP-mediated PKA subcellular anchoring.
Faruque OM; Le-Nguyen D; Lajoix AD; Vives E; Petit P; Bataille D; Hani EH
Am J Physiol Cell Physiol; 2009 Feb; 296(2):C306-16. PubMed ID: 19073898
[TBL] [Abstract][Full Text] [Related]
5. Identification of cAMP-dependent protein kinase holoenzymes in preantral- and preovulatory-follicle-enriched ovaries, and their association with A-kinase-anchoring proteins.
Carr DW; Cutler RE; Cottom JE; Salvador LM; Fraser ID; Scott JD; Hunzicker-Dunn M
Biochem J; 1999 Dec; 344 Pt 2(Pt 2):613-23. PubMed ID: 10567247
[TBL] [Abstract][Full Text] [Related]
6. Regulation of neuronal PKA signaling through AKAP targeting dynamics.
Dell'Acqua ML; Smith KE; Gorski JA; Horne EA; Gibson ES; Gomez LL
Eur J Cell Biol; 2006 Jul; 85(7):627-33. PubMed ID: 16504338
[TBL] [Abstract][Full Text] [Related]
7. Role of AKAP 149-PKA-PDE4A complex in cell survival and cell differentiation processes.
Fernández-Araujo A; Tobío A; Alfonso A; Botana LM
Int J Biochem Cell Biol; 2014 Aug; 53():89-101. PubMed ID: 24813785
[TBL] [Abstract][Full Text] [Related]
8. Investigating PKA-RII specificity using analogs of the PKA:AKAP peptide inhibitor STAD-2.
Bendzunas NG; Dörfler S; Autenrieth K; Bertinetti D; Machal EMF; Kennedy EJ; Herberg FW
Bioorg Med Chem; 2018 Mar; 26(6):1174-1178. PubMed ID: 29449124
[TBL] [Abstract][Full Text] [Related]
9. Sphingosine kinase interacting protein is an A-kinase anchoring protein specific for type I cAMP-dependent protein kinase.
Kovanich D; van der Heyden MA; Aye TT; van Veen TA; Heck AJ; Scholten A
Chembiochem; 2010 May; 11(7):963-71. PubMed ID: 20394097
[TBL] [Abstract][Full Text] [Related]
10. Identification and characterization of myeloid translocation gene 16b as a novel a kinase anchoring protein in T lymphocytes.
Schillace RV; Andrews SF; Liberty GA; Davey MP; Carr DW
J Immunol; 2002 Feb; 168(4):1590-9. PubMed ID: 11823486
[TBL] [Abstract][Full Text] [Related]
11. Analysis of A-kinase anchoring protein (AKAP) interaction with protein kinase A (PKA) regulatory subunits: PKA isoform specificity in AKAP binding.
Herberg FW; Maleszka A; Eide T; Vossebein L; Tasken K
J Mol Biol; 2000 Apr; 298(2):329-39. PubMed ID: 10764601
[TBL] [Abstract][Full Text] [Related]
12. A-kinase anchoring protein targeting of protein kinase A and regulation of HERG channels.
Li Y; Sroubek J; Krishnan Y; McDonald TV
J Membr Biol; 2008 May; 223(2):107-16. PubMed ID: 18679741
[TBL] [Abstract][Full Text] [Related]
13. Anchoring of both PKA and 14-3-3 inhibits the Rho-GEF activity of the AKAP-Lbc signaling complex.
Diviani D; Abuin L; Cotecchia S; Pansier L
EMBO J; 2004 Jul; 23(14):2811-20. PubMed ID: 15229649
[TBL] [Abstract][Full Text] [Related]
14. A dynamic interface between ubiquitylation and cAMP signaling.
Rinaldi L; Sepe M; Donne RD; Feliciello A
Front Pharmacol; 2015; 6():177. PubMed ID: 26388770
[TBL] [Abstract][Full Text] [Related]
15. PKA-type I selective constrained peptide disruptors of AKAP complexes.
Wang Y; Ho TG; Franz E; Hermann JS; Smith FD; Hehnly H; Esseltine JL; Hanold LE; Murph MM; Bertinetti D; Scott JD; Herberg FW; Kennedy EJ
ACS Chem Biol; 2015 Jun; 10(6):1502-10. PubMed ID: 25765284
[TBL] [Abstract][Full Text] [Related]
16. Survivin in Insulin-Like Growth Factor-Induced Resistance to Lapatinib in Head and Neck Squamous Carcinoma Cells.
Lehman CE; Mendez RE; Dougherty MI; Allak A; Adejumo OL; Taniguchi LE; Khalil A; Gioeli DG; Jameson MJ
Front Oncol; 2019; 9():13. PubMed ID: 30729097
[TBL] [Abstract][Full Text] [Related]
17. Luteolin sensitizes the antiproliferative effect of interferon α/β by activation of Janus kinase/signal transducer and activator of transcription pathway signaling through protein kinase A-mediated inhibition of protein tyrosine phosphatase SHP-2 in cancer cells.
Tai Z; Lin Y; He Y; Huang J; Guo J; Yang L; Zhang G; Wang F
Cell Signal; 2014 Mar; 26(3):619-28. PubMed ID: 24333668
[TBL] [Abstract][Full Text] [Related]
18. PGE2 potentiates tonicity-induced COX-2 expression in renal medullary cells in a positive feedback loop involving EP2-cAMP-PKA signaling.
Steinert D; Küper C; Bartels H; Beck FX; Neuhofer W
Am J Physiol Cell Physiol; 2009 Jan; 296(1):C75-87. PubMed ID: 19005164
[TBL] [Abstract][Full Text] [Related]
19. Potential therapeutic applications of AKAP disrupting peptides.
Murabito A; Cnudde S; Hirsch E; Ghigo A
Clin Sci (Lond); 2020 Dec; 134(24):3259-3282. PubMed ID: 33346357
[TBL] [Abstract][Full Text] [Related]
20. Stimulation of β₂-adrenergic receptors inhibits calcineurin activity in CD4(+) T cells via PKA-AKAP interaction.
Riether C; Kavelaars A; Wirth T; Pacheco-López G; Doenlen R; Willemen H; Heijnen CJ; Schedlowski M; Engler H
Brain Behav Immun; 2011 Jan; 25(1):59-66. PubMed ID: 20674738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
